Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022

SELL
$3.45 - $8.77 $10.1 Million - $25.8 Million
-2,941,556 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$8.01 - $12.84 $6.74 Million - $10.8 Million
-841,207 Reduced 22.24%
2,941,556 $23.9 Million
Q3 2021

Nov 12, 2021

SELL
$11.94 - $16.09 $10.5 Million - $14.1 Million
-876,255 Reduced 18.81%
3,782,763 $47.7 Million
Q2 2021

Aug 05, 2021

SELL
$14.36 - $20.93 $6.58 Million - $9.6 Million
-458,508 Reduced 8.96%
4,659,018 $72.1 Million
Q1 2021

May 13, 2021

SELL
$18.19 - $33.25 $28.4 Million - $51.9 Million
-1,561,551 Reduced 23.38%
5,117,526 $103 Million
Q4 2020

Feb 12, 2021

BUY
$15.87 - $31.64 $40.4 Million - $80.5 Million
2,543,994 Added 61.52%
6,679,077 $181 Million
Q3 2020

Oct 30, 2020

BUY
$15.7 - $20.84 $21.3 Million - $28.3 Million
1,355,756 Added 48.78%
4,135,083 $76.5 Million
Q2 2020

Aug 11, 2020

BUY
$8.21 - $21.02 $10.1 Million - $25.9 Million
1,231,281 Added 79.54%
2,779,327 $49.5 Million
Q1 2020

May 14, 2020

BUY
$7.81 - $18.82 $1.61 Million - $3.88 Million
206,045 Added 15.35%
1,548,046 $14.2 Million
Q4 2019

Jan 31, 2020

BUY
$9.73 - $19.31 $993,802 - $1.97 Million
102,138 Added 8.24%
1,342,001 $23 Million
Q3 2019

Nov 12, 2019

BUY
$10.15 - $16.89 $1.39 Million - $2.31 Million
136,677 Added 12.39%
1,239,863 $12.9 Million
Q2 2019

Jul 30, 2019

BUY
$14.6 - $20.6 $2.47 Million - $3.48 Million
169,110 Added 18.1%
1,103,186 $17.2 Million
Q1 2019

May 13, 2019

BUY
$15.53 - $19.75 $3.41 Million - $4.34 Million
219,740 Added 30.76%
934,076 $17.1 Million
Q4 2018

Feb 01, 2019

BUY
$15.58 - $28.41 $4.99 Million - $9.1 Million
320,294 Added 81.28%
714,336 $11.9 Million
Q3 2018

Nov 07, 2018

BUY
$25.99 - $30.6 $3.89 Million - $4.58 Million
149,779 Added 61.32%
394,042 $11.1 Million
Q2 2018

Aug 07, 2018

BUY
$27.78 - $38.53 $4.35 Million - $6.04 Million
156,666 Added 178.85%
244,263 $6.91 Million
Q1 2018

May 14, 2018

BUY
$27.78 - $35.19 $1.2 Million - $1.52 Million
43,215 Added 97.37%
87,597 $2.76 Million
Q4 2017

Feb 12, 2018

BUY
$23.33 - $35.01 $654,359 - $981,960
28,048 Added 171.72%
44,382 $1.29 Million
Q3 2017

Nov 09, 2017

BUY
$21.65 - $32.18 $266,208 - $395,685
12,296 Added 304.51%
16,334 $465,000
Q2 2017

Aug 11, 2017

BUY
N/A
1,784 Added 79.15%
4,038 $104,000
Q1 2017

May 15, 2017

BUY
N/A
2,254
2,254 $54,000

Others Institutions Holding CLLS

About Cellectis S.A.


  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $71.5M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.